Evolus (NASDAQ:EOLS – Get Free Report) and Clever Leaves (NASDAQ:CLVR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Risk and Volatility Evolus has a beta of […]
Colombian cannabis company Sannabis makes U.S. debut with essential oil shipment, navigating regulatory hurdles while exploring industry potential and partnerships
Clever Leaves shares are trading lower by 62% during Monday's session. The company announced that it will voluntarily delist its common shares from the Nasdaq.